Although this association did not reach statistical significance, likely because of the small sample size ( N = 7), none of these patients experienced liver progression during ICI therapies.
← all excerpts
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors.
2
—
—
The sentences
In LEAP-017, patients without liver metastases showed a trend toward improved OS (HR, 0.65; 95% CI, 0.42–0.99), whereas those with liver metastases derived minimal benefit (HR, 0.91; 95% CI, 0.72–1.15; ref. 25 ).